Correlation Between Angion Biomedica and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both Angion Biomedica and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Angion Biomedica and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Angion Biomedica Corp and Cue Biopharma, you can compare the effects of market volatilities on Angion Biomedica and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Angion Biomedica with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Angion Biomedica and Cue Biopharma.
Diversification Opportunities for Angion Biomedica and Cue Biopharma
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Angion and Cue is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Angion Biomedica Corp and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Angion Biomedica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Angion Biomedica Corp are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Angion Biomedica i.e., Angion Biomedica and Cue Biopharma go up and down completely randomly.
Pair Corralation between Angion Biomedica and Cue Biopharma
If you would invest 1,000.00 in Angion Biomedica Corp on September 1, 2024 and sell it today you would earn a total of 0.00 from holding Angion Biomedica Corp or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 4.76% |
| Values | Daily Returns |
Angion Biomedica Corp vs. Cue Biopharma
Performance |
| Timeline |
| Angion Biomedica Corp |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Cue Biopharma |
Angion Biomedica and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Angion Biomedica and Cue Biopharma
The main advantage of trading using opposite Angion Biomedica and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Angion Biomedica position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| Angion Biomedica vs. Apollomics Class A | Angion Biomedica vs. Pyxis Oncology | Angion Biomedica vs. Zura Bio Limited | Angion Biomedica vs. Altamira Therapeutics |
| Cue Biopharma vs. Tff Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics | Cue Biopharma vs. Inhibrx | Cue Biopharma vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |